Effect of mineralocorticoid receptor antagonist at baseline on the efficacy of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Effect of mineralocorticoid receptor antagonist at baseline on the efficacy of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a meta-analysis of randomized controlled trials

Published:2022-08-08 Issue:14 Volume:29 Page:e334-e337
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:

Author:

Arshad Muhammad Sameer¹,Ahmed Aymen¹^ORCID,Ejaz Arooba¹,Ahmed Warda²,Farooqi Shaikh Muhammad Habibullah¹,Memon Muhammad Mustafa¹,Shahid Izza³

Affiliation:

1. Department of Medicine, Dow University of Health Sciences , 74200 Baba-e-Urdu Road, Karachi, Sindh , Pakistan

2. Department of Medicine, Aga Khan University , 74800 Stadium Road, Karachi, Sindh , Pakistan

3. Department of Medicine, Ziauddin University , 75510 Shahrah-e-Iran Clifton Road, Karachi, Sindh , Pakistan

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

https://academic.oup.com/eurjpc/advance-article-pdf/doi/10.1093/eurjpc/zwac171/45497569/zwac171.pdf

Reference9 articles.

1. Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives;Pitt;Eur Heart Journal Cardiovasc Pharmacother,2017

2. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC;McDonagh;Eur J Heart Fail,2022

3. Dapagliflozin in HFrEF patients treated with mineralocorticoid receptor antagonists: an analysis of DAPA-HF;Shen;JACC Heart Fail,2021

4. Interplay of mineralocorticoid receptor antagonists and empagliflozin in heart failure: EMPEROR-reduced;Ferreira;J Am Coll Cardiol,2021

5. Mineralocorticoid receptor antagonists and empagliflozin in patients with heart failure and preserved ejection fraction;Ferreira;J Am Coll Cardiol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 inhibitors in heart failure: a meta-analysis;European Heart Journal;2023-08-22

2. Editorial comments: Focus on pharmacological management;European Journal of Preventive Cardiology;2022-10-01